Literature DB >> 17469814

Ternary iron(III) complex showing photocleavage of DNA in the photodynamic therapy window.

Mithun Roy1, Sounik Saha, Ashis K Patra, Munirathinam Nethaji, Akhil R Chakravarty.   

Abstract

A new ternary iron(III) complex [FeL(dpq)] containing dipyridoquinoxaline (dpq) and 2,2-bis(3,5-di-tert-butyl-2-hydroxybenzyl)aminoacetic acid (H3L) is prepared and structurally characterized by X-ray crystallography. The high-spin complex with a FeN3O3 core shows a quasi-reversible iron(III)/iron(II) redox couple at -0.62 V (vs SCE) in DMF/0.1 M TBAP and a broad visible band at 470 nm in DMF/Tris buffer. Laser photoexcitation of this phenolate (L)-to-iron(III) charge-transfer band at visible wavelengths including red light of >or=630 nm leads to cleavage of supercoiled pUC19 DNA to its nicked circular form via a photoredox pathway forming hydroxyl radicals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17469814     DOI: 10.1021/ic062056l

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

Authors:  Nicola J Farrer; Luca Salassa; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-11-11       Impact factor: 4.390

2.  Studies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes.

Authors:  Yata Praveen Kumar; C Shobha Devi; A Srishailam; N Deepika; V Ravi Kumar; P Venkat Reddy; K Nagasuryaprasad; Surya S Singh; Penumaka Nagababu; S Satyanarayana
Journal:  J Fluoresc       Date:  2016-09-02       Impact factor: 2.217

3.  Fluorescent Imidazo[1,5-a]pyridinium Salt for a Potential Cancer Therapy Agent.

Authors:  Fumitoshi Yagishita; Jun-Ichi Tanigawa; Chiho Nii; Atsushi Tabata; Hideaki Nagamune; Hiroki Takanari; Yasushi Imada; Yasuhiko Kawamura
Journal:  ACS Med Chem Lett       Date:  2019-07-24       Impact factor: 4.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.